Should DEHP be eliminated in blood bags?

Vox Sanguinis

Volumn 106, Issue 2, 2014, Pages 176-195

  Van Der Meer, P F ^a   Reesink, H W ^b   Panzer, S ^c   Wong, J ^d   Ismay, S ^d   Keller, A ^e   Pink, J ^e   Buchta, C ^f   Compernolle, V ^g   Wendel, S ^h   Biagini, S ^h   Scuracchio, P ^h   Thibault, L ⁱ   Germain, M ⁱ   Georgsen, J ^j   Begue S ^k   Dernis, D ^k   Raspollini, E ^l   Villa, S ^l   Rebulla, P ^l   Takanashi, M ^m   de Korte, D ⁿ   Lozano, M ^o   Cid, J ^o   Gulliksson, H ^p   Cardigan, R ^q   Tooke, C ^r   Fung, M K ^r   Luban, N L C ^s   Vassallo, R ^t   Benjamin, R ^t   more..

^a Sanquin Blood Bank ^*  (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d Australian Red Cross Blood Service   (Australia)

^e AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^f Cyto Care   (Austria)

^g Rode Kruis Vlaanderen   (Belgium)

^h HOSPITAL SÍRIO LIBANÊS   (Brazil)

ⁱ HÉMA QUÉBEC   (Canada)

^j ODENSE UNIVERSITY HOSPITAL   (Denmark)

^k ETABLISSEMENT FRANÇAIS DU SANG   (France)

^l FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^m SUWA RED CROSS HOSPITAL   (Japan)

ⁿ CENTRAL LABORATORY   (Netherlands)

^o HOSPITAL CLÍNIC   (Spain)

^p KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^q NHS BLOOD AND TRANSPLANT   (United Kingdom)

^r UNIVERSITY OF VERMONT   (United States)

^s GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^t AMERICAN RED CROSS BLOOD SERVICES   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; PLASTICIZER; POLYVINYLCHLORIDE; THYROID HORMONE;

APHERESIS; ARTICLE; BACTERIUM CONTAMINATION; BLOOD COMPONENT; BLOOD TRANSFUSION; DNA DAMAGE; HUMAN; INFUSION SYSTEM; LEACHING; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; SPERM; URINALYSIS;

ADOLESCENT; BLOOD SPECIMEN COLLECTION; DIETHYLHEXYL PHTHALATE; FEMALE; HUMANS; MALE; PLASTICIZERS;

EID: 84892853051     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12099     Document Type: Article

References (63)

1. Walter CW, Murphy WP: A closed gravity technique for the preservation of whole blood in ACD solution utilising plastic equipment. Surg Gynaecol Obstet 1952; 94:687-692.
2. Walter CW: Invention and development of the blood bag. Vox Sang 1984; 47:318-324.
3. Horowitz B, Stryker MH, Waldman AA, et al.: Stabilization of red blood cells by the plasticizer, diethylhexylphthalate. Vox Sang 1985; 48:150-155.
4. Autian J: Toxicity and health threats of phthalate esters: review of the literature. Environ Health Perspect 1973; 4:3-26.
5. Gesler RM: Toxicology of di-2-ethylhexylphthalate and other phthalic acid ester plasticizers. Environ Health Perspect 1973; 3:73-79.
6. Sampson J, De Korte D: DEHP-plasticised PVC: relevance to blood services. Transfusion Medicine 2011; 21:73-83.
7. Jönsson BA, Richthoff J, Rylander L, et al.: Urinary phthalate metabolites and biomarkers of reproductive function in young men. Epidemiology 2005; 16:487-493.
8. Hauser R, Meeker JD, Singh NP, et al.: DNA damage in human sperm is related to urinary levels of phthalate monoester and oxidative metabolites. Hum Reprod 2007; 22:688-695.
9. Desdoits-Lethimonier C, Albert O, Le Bizec B, et al.: Human testis steroidogenesis is inhibited by phthalates. Hum Reprod 2012; 27:1451-1459.
10. Joensen UN, Frederiksen H, Jensen MB, et al.: Phthalate excretion pattern and testicular function: a study of 881 healthy Danish men. Environ Health Perspect 2012; 120:1397-1403.
11. Meeker JD, Calafat AM, Hauser R: Di(2-ethylhexyl) phthalate metabolites may alter thyroid hormone levels in men. Environ Health Perspect 2007; 115:1029-1034.
12. Swan SH: Environmental phthalate exposure in relation to reproductive outcomes and other health endpoints in humans. Environ Res 2008; 108:177-184.
13. Rais-Bahrami K, Nunez S, Revenis ME, et al.: Follow-up study of adolescents exposed to di(2-ethylhexyl) phthalate (DEHP) as neonates on extracorporeal membrane oxygenation (ECMO) support. Environ Health Perspect 2004; 112: 1339-1340.
14. Latini G, De Felice C, Presta G, et al.: In utero exposure to di-(2-ethylhexyl)phthalate and duration of human pregnancy. Environ Health Perspect 2003; 111:1783-1785.
15. Huber WW, Grasl-Kraupp B, Schulte-Hermann R: Hepatocarcinogenic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk. Crit Rev Toxicol 1996; 26:365-481.
16. Koch HM, Drexler H, Angerer J: An estimation of the daily intake of di(2-ethylhexyl)phthalate (DEHP) and other phthalates in the general population. Int J Hyg Environ Health 2003; 206:77-83.
17. Wittassek M, Wiesmüller GA, Koch HM, et al.: Inner burden to phthalate plasticizers over the last two decades - a retrospective human biomonitoring study. Int J Hyg Environ Health 2007; 210:319-333.
18. Wittassek M, Heger W, Koch HM, et al.: Daily intake of di(2- ethylhexyl)phthalate (DEHP) by German children - a comparison of two estimation models based on urinary DEHP metabolite levels. Int J Hyg Environ Health 2007; 210:35-42.
19. Rock G, Secours VE, Franklin CA, et al.: The accumulation of mono-2-ethylhexyl phthalate (MEHP) during storage of whole blood and plasma. Transfusion 1978; 18:553-558.
20. Wittassek M, Angerer J: Phthalates: metabolism and exposure. Int J Androl 2008; 31:131-138.
21. Buchta C, Bittner C, Heinzl H, et al.: Transfusion-related exposure to the plasticizer di(2-ethylhexyl)phthalate in patients receiving plateletpheresis concentrates. Transfusion 2005; 45:798-802.
22. Sampson J, de Korte D: DEHP-plasticised PVC: relevance to blood services. Transfusion Medicine 2011; 21:73-83.
23. Shaz BH, Grima K, Hillyer CD: 2-(Diethylhexyl)phthalate in blood bags: is this a public health issue? Transfusion 2011; 51:2510-2517.
24. Simmchen J, Ventura R, Segura J: Progress in the removal of di-[2-ethylhexyl]-phthalate as plasticizer in blood bags. Transfus Med Rev 2011; 26:27-37.
25. Koch HM, Angerer J, Drexler H, et al.: Di(2-ethylhexyl)phthalate (DEHP) exposure of voluntary plasma and platelet donors. Int J Hyg Environ Health 2005; 208:489-498.
26. Buchta C, Bittner C, Hocker P, et al.: Donor exposure to the plasticizer di(2-ethylhexyl)phthalate during plateletpheresis. Transfusion 2003; 43:1115-1120.
27. Buchta C, Bittner C, Heinzl H, et al.: Transfusion-related exposure to the plasticizer di(2-ethylhexyl)phthalate in patients receiving plateletpheresis concentrates. Transfusion 2005; 45:798-802.
28. Buchta C, Bittner C, Höcker P, et al.: Donor exposure to the plasticizer di(2-ethylhexyl)phthalate during plateletpheresis. Transfusion 2003; 43:1115-1120.
29. Sampson J, de Korte D: DEHP-plasticised PVC: relevance to blood services. Transfus Med 2011; 21:73-83.
30. Brasil. Agȩncia Nacional de Vigila̧ncia Sanitária: Manual de Tecnovigila̧ncia: abordagens de vigila̧ncia sanitária de produtos para saúde comercializados no Brasil. Brasília-DF 2010; 442-451. (Retrieved from: http://portal.anvisa.gov.br/ wps/wcm/connect/378e9d00474587af9170d53fbc4c6735/man ual_tecnovigilancia.pdf)
31. Myhre BA, Johnson D, Marcus CS, et al.: Survival of Red Cells Stored for 21 and 35 Days in a Non-Di-(2-Ethylhexyl) Phthalate Plastic Container. Vox Sang 1987; 53:199-202.
32. AuBuchon JP, Estep TN, Davey RJ: The effect of the plasticizer di-2-ethylhexyl phthalate on the survival of stored RBCs. Blood 1988; 71:448-452.
33. Sampson J, De Korte D: DEHP-plasticised PVC: relevance to blood services. Transfusion Medicine 2011; 21:73-83.
34. Phthalates Regulations, Canada Consumer Product Safety Act; SOR/2010-298. Canada, 2011.
35. Dumont LJ, Baker S, Dumont DF, et al.: Exploratory in vitro study of red blood cell storage containers formulated with an alternative plasticizer. Transfusion 2012; 52:439-445.
36. Buchta C, Bittner C, Hocker P, et al.: Donor exposure to the plasticizer di(2-ethylhexyl)phthalate during plateletpheresis. Transfusion 2003; 43:1115-1120.
37. Koch HM, Angerer J, Drexler H, et al.: Di(2-ethylhexyl)phthalate (DEHP) exposure of voluntary plasma and platelet donors. Int J Hyg Environ Health 2005; 208:489-498.
38. Cairns T, Chiu KS, Siegmund EG, et al.: Levels of plasticizer in the frequent plasma donor. Biomed Environ Mass Spectrom 1986; 13:357-360
39. SCENIHR -22nd Plenary of 6 February 2008. http://ec.europa. eu/health/ph_risk/risk_en.htm
40. Fontaine O, Melique S, Doolaeghe MC, et al.: Dehp-free containers for collection, processing and storage of Labile Blood Products - Comparative Evaluation of FFPS. Vox Sang 2012; 103(Suppl. 1):116.
41. Goudaliez F, Verpoort T, Poplineau J, et al.: Labile blood components collected, processed and stored in DEHP-free containers. Vox Sang 2011; 101(Suppl. 1):164.
42. Dumont LJ, Baker S, Dumont DF, et al.: Exploratory in vitro study of red blood cell storage containers formulated with an alternative plasticizer. Transfusion 2012; 52:1439-1445.
43. Sampson J, de Korte D: DEHP-plasticized PVC: relevance to blood services. Transfus Med 2011; 21:73-83.
44. AuBuchon JP, Estep TN, Davey RJ: The effect of the plasticizer di-2-ethyl phthalate on the survival of stored RBCs. Blood 1989; 71:448-452.
45. Dumont LJ, Baker S, Dumont DF, et al.: Exploratory in vitro study of red cell storage containers formulated with an alternative plasticizer. Transfusion 2012; 52:1439-1445.
46. Bhaskaran Nair CS, Vidya R, Ashalatha PM. Hexamoll DINCH plasticized containers for the storage of platelets. Asian J Transfus Sci 2011;5:18-22
47. Inoue K, Kawaguchi M, Yamanaka R, et al.: Evaluation and analysis of exposure levels of di(2-ethylhexyl) phthalate from blood bags. Clin Chim Acta 2005; 358:159-166
48. Yoshizawa K. Standardizing analysis methods for safe blood for transfusion. Research report for a Science Research Grant from the Ministry of Health, Labour and Welfare. 200301268A, March 2004 (in Japanese) [cited 7 January 2013]. Available from: http://mhlw-grants.niph.go.jp/niph/search/NISR00.do
49. Center for Devices and Radiological Health. Safety assessment of di(2-ethylhexyl)phthalate (DEHP) released from PVC medical devices. U.S. Food and Drug Administration. Rockville, MD, 2002. [cited 17 December 2012]. Available from: http://www. fda.gov/downloads/MedicalDevices/DeviceRegulationandGuid ance/GuidanceDocuments/UCM080457.pdf
50. Pharmaceuticals and Medical Devices Safety Information No. 182. Ministry of Health, Labour and Welfare, Pharmaceutical and Food Safety Bureau, October 2002. (in Japanese) [cited 4 January 2013]. Available from: http://www.info.pmda.go.jp/ iyaku_anzen/PMDSI182d.html#12
51. Further actions to endocrine disrupting effects of chemical substances, -EXTEND 2010- Ministry of the Environment, July 2010. [cited 4 January 2013]. Available from: www.env. go.jp/chemi/end/extend2010/extend2010_full.pdf (in Japanese), www.env.go.jp/en/chemi/ed/extend2010_full.pdf (tentative translation)
52. Tooke C, Fung M. Awareness and demand for plasticizer-free blood bags and I.V. tubing: a survey of U.S. academic medical centers. Transfusion 2012; 52(Suppl. S3):175A.
53. Van Vliet ED, Reitano EM, Chhabra JS, et al.: A review of alternatives to di (2-ethylhexyl) phthalate-containing medical devices in the neonatal intensive care unit. J Perinatol 2011; 31:551-560.
54. http://www.fda.gov/downloads/MedicalDevices/DeviceRegulat ionandGuidance/GuidanceDocuments/UCM080457.pdf
55. http://www.fda.gov/medicaldevices/safety/alertsandnotices/ ucm062182.htm
56. Health Care Without Harm. www.noharm.org/
57. Dumont LJ, Baker S, Dumont DF, et al.: Exploratory in vitro study of red blood cell storage containers formulated with an alternative plasticizer. Transfusion 2012; 52:1439-1445.
58. Seidl S, Gozda W, Reppucci AJ: The in vitro and in vivo evaluation of whole blood and red cell concentrates drawn on CPDA-1 and stored in a non-DEHP plasticized PVC container. Vox Sang 1991; 61:8-13.
59. Hess JR: Scientific problems in the regulation of red blood cell products. Transfusion 2012; 52:827-835.
60. Buchta C, Dettke M: Di(2-ethylhexyl)phthalate exposure of apheresis donors is procedure-related (letter). Transfusion 2006; 46:1457-1459.
61. Center for the Evaluation of Risks to Human Reproduction: NTP-CERHR monograph on the potential human reproductive and developmental effects of di(2-ethylhexyl) phthalate (DEHP). National Toxicology Program, U.S. Department of Health and Human Services. Research Triangle Park, 2006.
62. FDA Public Health Notification: PVC Devices Containing the Plasticizer DEHP. US Food and Drug Administration, Bethesda, 2002. Available at: http://www.fda.gov/MedicalDevices/Saf ety/AlertsandNotices/PublicHealthNotifications/ucm062182. htm
63. Guidance for Industry Limiting the Use of Certain Phthalates as Excipients in CDER-Regulated Products. US Food and Drug Administration/CDER. Bethesda, 2012. Available at: http:// www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM294086.pdf